Position in VCYT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$176,190
+$47,350 QoQ
Shares Held
3,000
-25.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#260
of 367 holders
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VCYT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Quent Capital, LLC holds $4,245,733 across 20 Diagnostics & Research names. VCYT ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
4,356 | $1,182,436 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
2,348 | $1,177,193 | |
| 3 | DHR |
Danaher Corp /De/
|
2,582 | $491,819 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
262 | $334,707 | |
| 5 | A |
Agilent Technologies, Inc.
|
1,746 | $231,921 | |
| 6 | VCYT |
Veracyte, Inc.
This page
|
3,000 | $176,190 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
225 | $118,449 | |
| 8 | RVTY |
Revvity, Inc.
|
851 | $94,682 |
All Filings in VCYT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $176,190 | 3,000 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $128,840 | 4,000 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $168,400 | 4,000 | Shares | Sole | 2026-01-29 | |
| 2025-03-31 | $336,646 | 11,354 | Shares | Sole | 2025-04-04 | |
| 2024-12-31 | $889,891 | 22,472 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $764,946 | 22,472 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $486,968 | 22,472 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $497,979 | 22,472 | Shares | Sole | 2024-06-28 | |
| 2023-06-30 | $12,735 | 500 | Shares | Sole | 2024-06-17 | |
| No filing history on record for this holder in this stock. | ||||||